Key Takeaways
- Cerebras (CBRS) delivers its inaugural quarterly results as a publicly traded entity Tuesday evening, with analysts forecasting Q1 revenue around $183M, marking an 82%+ year-over-year increase.
- Options markets suggest a potential price swing of approximately 13% in either direction through week’s end.
- Shares debuted at $185 in May, peaked at $386 during the first trading session, and settled at $224.43 on Monday.
- Analyst consensus across 11 firms shows a Buy recommendation with a $294 average target price.
- Insider selling becomes possible Thursday when lock-up restrictions lift on nearly 13% of IPO-issued shares.
Cerebras Systems prepares to unveil its inaugural quarterly financial report Tuesday evening following market close. This milestone represents a critical test for the chip manufacturer since its high-profile May public offering, with significant implications for investor confidence.
Shares launched at $185 and rocketed to $386 during the debut trading day. The subsequent weeks have delivered considerable volatility. In 19 out of 25 sessions since going public, the stock experienced daily moves exceeding 3%. Monday’s closing price stood at $224.43.
Market participants anticipate substantial price action. Current options market dynamics indicate traders are positioning for CBRS to fluctuate approximately 13% in either direction through Friday. This projection places potential upside near $254, while downside risk extends below $195.
Wall Street consensus points toward Q1 revenue between $181 million and $183 millionārepresenting an 82% year-over-year expansion. Despite robust top-line growth, profitability remains elusive, with analysts projecting an adjusted loss per share of 16 cents.
The OpenAI Partnership
Central to Cerebras’ investment thesis is its $20 billion multi-year cloud infrastructure agreement with OpenAI. The artificial intelligence leader currently leverages Cerebras’ cloud platform to operate Codex-Spark, a specialized coding model.
Investors must grasp the contra-revenue complexity, however. Cerebras issued OpenAI warrants covering 33.4 million shares at essentially zero cost. As these warrants vest progressively, their fair value reduces reported revenue. During Q1, 4.5 million shares vested. Needham analyst Quinn Bolton anticipates the charge will remain manageable initially but expand substantially as the OpenAI relationship scales.
To provide transparency, Cerebras plans to disclose a “core revenue” metric that strips out contra-revenue impacts.
The company has also secured a binding term sheet with Amazon Web Services, potentially making AWS the first major cloud infrastructure provider to deploy Cerebras silicon.
As 2025 concluded, the company reported a backlog of $24.6 billion, almost exclusively attributable to the OpenAI contract. Management projects recognizing $3.7 billion of this backlog as revenue throughout 2026 and 2027.
Lock-Up Watch
A significant near-term concern centers on Thursday’s lock-up expiration. This event releases nearly 13% of IPO shares for potential sale by insiders and early-stage investors. The influx of available supply could pressure share prices.
The IPO itself represented only approximately 15% of total outstanding shares. Remaining holdings remain restricted, with a secondary unlock scheduled for two days following the Q2 earnings announcement.
Eleven Wall Street firms have published initial coverage. The consensus target price sits at $294, with major institutions including Wedbush ($270), UBS ($300), and Morgan Stanley ($250) maintaining Buy ratings. Analysts forecast core revenue reaching $7.2 billion by 2028, alongside adjusted EPS of $5.53. Based on Monday’s closing price, shares trade at 41 times projected 2028 earnings.
Since Q1 concluded in Marchāprior to the public offeringāthe upcoming report won’t reflect balance sheet or cash flow changes resulting from the IPO proceeds.





